{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:24:47Z","timestamp":1793316287022,"version":"4.5.0"},"reference-count":73,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["mAbs"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1080\/19420862.2020.1725346","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:07:21Z","timestamp":1581638841000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":24,"title":["Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapy"],"prefix":"10.1080","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5037-0611","authenticated-orcid":false,"given":"Rita","family":"De Santis","sequence":"first","affiliation":[{"name":"Alfasigma SpA","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-019-01714-4"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2018.10.003"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1556465"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-019-02984-2"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2018.11.004"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2018.12.003"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-019-0174-7"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2018.1467270"},{"key":"e_1_3_3_10_1","unstructured":"Herceptin EPAR product information. EMA web site. www.ema.europa.eu"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2017.12.006"},{"key":"e_1_3_3_12_1","unstructured":"Perjeta EPAR product information. EMA web site www.ema.europa.eu"},{"key":"e_1_3_3_13_1","unstructured":"Can roche\u2019s blockbuster drug herceptin\u2019s sales grow?; December 2019. www.forbes.com."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L504"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462315000094"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.5539\/gjhs.v7n1p98"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.01.012"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1185013"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2018.1386559"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-3958-x"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-016-0386-z"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2930"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30501-6"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.2017.108.issue-7"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1503904"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v9i98"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2018.1531158"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30870"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32408"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30088-9"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30097-X"},{"key":"e_1_3_3_32_1","unstructured":"FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies. FDA news release; 2019 Dec 20. www.fda.gov."},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0480-z"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13552"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0957"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00359-0"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.26.4220"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211783"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.08.019"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2019.1633306"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-NB2019-069"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000381"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.25"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11562"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040563"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30328-6"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2019-CT053"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.4509"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/antib8010011"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.7b00365"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-019-0633-6"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17558"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-NB2018-151"},{"key":"e_1_3_3_54_1","unstructured":"Zymeworks\u2019 lead asset ZW25 granted fast track designation from the FDA [news release]. Vancouver (BC); Zymeworks Inc; 2019 May 29. https:\/\/bit.ly\/2Mt6iJQ."},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1486946"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.04.003"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1354-1"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060870"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S198552"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12554"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091268"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1541370"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0073-7"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.080457"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2011.00701.x"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-017-0754-3"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2015.1837"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/921434"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2009.0738"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021075"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15145"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6089"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2409"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01534"}],"container-title":["mAbs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/19420862.2020.1725346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:03:12Z","timestamp":1762430592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/19420862.2020.1725346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1080\/19420862.2020.1725346"],"URL":"https:\/\/doi.org\/10.1080\/19420862.2020.1725346","relation":{},"ISSN":["1942-0862","1942-0870"],"issn-type":[{"value":"1942-0862","type":"print"},{"value":"1942-0870","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kmab20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kmab20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1725346"}}